Spruce Biosciences GAAP EPS of -$0.21 beats by $0.04 Nov. 11, 2024 12:47 PM ET By: Harsh Shukla , SA News Editor [Seeking Alpha]
Spruce Biosciences, Inc. (SPRB)
Company Research
Source: Seeking Alpha
The collaboration revenue reflects the partial recognition of the $15M upfront payment the company received in April 2023 in connection with the collaboration and license agreement with Kaken Pharmaceutical. The company had cash and cash equivalents of $60.1M as of September 30, 2024. More on Spruce Biosciences Seeking Alpha's Quant Rating on Spruce Biosciences Historical earnings data for Spruce Biosciences Financial information for Spruce Biosciences Recommended For You Comments More Trending News
Show less
Read more
Impact Snapshot
Event Time:
SPRB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SPRB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SPRB alerts
High impacting Spruce Biosciences, Inc. news events
Weekly update
A roundup of the hottest topics
SPRB
News
- Spruce Biosciences, Inc. (NASDAQ: SPRB) had its "neutral" rating re-affirmed by analysts at HC Wainwright.MarketBeat
- Spruce Biosciences, Inc. (NASDAQ: SPRB) had its "neutral" rating re-affirmed by analysts at Guggenheim.MarketBeat
- Spruce Biosciences, Inc. (NASDAQ: SPRB) was downgraded by analysts at Citizens Jmp from a "strong-buy" rating to a "hold" rating.MarketBeat
- Spruce Biosciences, Inc. (NASDAQ: SPRB) had its "sector perform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $1.50 price target on the stock, down previously from $2.00.MarketBeat
- Spruce Biosciences, Inc. (NASDAQ: SPRB) had its "market perform" rating re-affirmed by analysts at JMP Securities.MarketBeat
SPRB
Sec Filings
- 12/20/24 - Form 4
- 12/20/24 - Form 4
- 12/20/24 - Form 4
- SPRB's page on the SEC website